ODDB.org: Open Drug Database

Spirig HealthCare AG - Co-Olmesartan Amlo Spirig HC 20 mg/5 mg/12.5 mg, Filmtabletten

Swissmedic Registration	67447	Sequence	01
Product name	Co-Olmesartan Amlo Spirig HC 20 mg/5 mg/12.5 mg	Description	Filmtabletten
ATC-Classification	C09DX03	ATC-Description	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Introduction of Sequence	22.04.2020

Composition

olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, lactosum monohydricum 102.565 mg, Überzug: hypromellosum, lactosum monohydricum 1.96 mg, macrogolum 4000, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Amlodipine	5 mg
Hydrochlorothiazide	12.5 mg
Olmesartanum Medoxomilum	20 mg

BAG: Active Agent	Dose
Amlodipine	5 mg
Hydrochlorothiazide	12.5 mg
Olmesartan Medoxomil	20 mg

Inactive agents	Dose	additional_information
(Flavum)
(Nigrum)
(Rubrum)
Cellulosum Microcristallinum
Crospovidonum
E 171		color.
E 172		color.
Hypromellosum		Überzug
Lactose Monohydrate	1.96 mg
Macrogol	4000
Magnesii Stearas
Pro Compresso Obducto
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30	17.06	34.90	B	SL	Yes
002	100	46.40	66.85	B	SL	Yes

2025	©ywesee GmbH